Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Revenue
Prestige Consumer Healthcare Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Revenue
$1.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
Johnson & Johnson
NYSE:JNJ
|
Revenue
$81.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Revenue
$45B
|
CAGR 3-Years
2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Revenue
$58.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
1%
|
|
Merck & Co Inc
NYSE:MRK
|
Revenue
$60.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Eli Lilly and Co
NYSE:LLY
|
Revenue
$34.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
Prestige Consumer Healthcare Inc
Revenue Breakdown
Breakdown by Geography
Prestige Consumer Healthcare Inc
Total Revenue:
1.1B
USD
|
United States:
953.2m
USD
|
Rest Of World:
174.5m
USD
|
Breakdown by Segments
Prestige Consumer Healthcare Inc
Total Revenue:
1.1B
USD
|
Net Sales:
1.1B
USD
|
North American Otc Healthcare:
973.8m
USD
|
Women's Health:
251.4m
USD
|
Gastrointestinal:
226.6m
USD
|
Eye & Ear Care:
171.1m
USD
|
International Otc Healthcare:
154m
USD
|
Cough & Cold:
127m
USD
|
Dermatologicals:
123.7m
USD
|
Analgesics:
119.3m
USD
|
Oral Care:
97.6m
USD
|
Other Otc:
11.1m
USD
|
Other Revenues:
107k
USD
|
See Also
What is Prestige Consumer Healthcare Inc's Revenue?
Revenue
1.1B
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Revenue amounts to 1.1B USD.
What is Prestige Consumer Healthcare Inc's Revenue growth rate?
Revenue CAGR 10Y
6%
Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Prestige Consumer Healthcare Inc have been 6% over the past three years , 3% over the past five years , and 6% over the past ten years .